UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo

Lupus, 2003-01, Vol.12 (9), p.677-686

2003

Volltextzugriff (PDF)

Prophylaxis of the antiphospholipid syndrome: a consensus report

Lupus, 2003-01, Vol.12 (7), p.499-503

2003

Volltextzugriff (PDF)

Vasculitis in systemic lupus erythematosus

Lupus, 1997-01, Vol.6 (3), p.235-242

1997

Volltextzugriff (PDF)

Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis

Genes and immunity, 2004-03, Vol.5 (2), p.130-137

2004

Volltextzugriff (PDF)

Primary antiphospholipid syndrome

Journal of rheumatology, 1989-04, Vol.16 (4), p.482

1989

Volltextzugriff (PDF)

Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients

Journal of rheumatology, 1989-03, Vol.16 (3), p.328

1989

Volltextzugriff (PDF)

Vasculitis and the antiphospholipid syndrome

British journal of rheumatology, 2000-08, Vol.39 (8), p.922-923

2000

Volltextzugriff (PDF)

Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices

Journal of rheumatology, 1992-10, Vol.19 (10), p.1551

1992

Volltextzugriff (PDF)

Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus

Lupus, 2004-01, Vol.13 (1), p.4-10

2004

Volltextzugriff (PDF)

Antinuclear antibodies: to penetrate or not to penetrate, that was the question

Lupus, 2001-01, Vol.10 (5), p.315-318

Alarco, D

2001

Volltextzugriff (PDF)

Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin

Lupus, 2004-01, Vol.13 (1), p.45-53

2004

Volltextzugriff (PDF)

Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies

Lupus, 2000-01, Vol.9 (7), p.545-547

2000

Volltextzugriff (PDF)

The recovery of self tolerance in SLE

Lupus, 2001-01, Vol.10 (8), p.521-522

Alarcón-Segovia, D

2001

Volltextzugriff (PDF)

Penetration of autoantibodies into living cells, 2000

The Israel Medical Association journal, 2001-02, Vol.3 (2), p.121-126

2001

Volltextzugriff (PDF)

Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus

Journal of rheumatology, 1994-06, Vol.21 (6), p.1067

1994

Volltextzugriff (PDF)

Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission

Lupus, 2003-01, Vol.12 (5), p.386-393

2003

Volltextzugriff (PDF)

The future of treatment for systemic lupus erythematosus

The Israel Medical Association journal, 2001-02, Vol.3 (2), p.127-130

Alarcón-Segovia, D

2001

Volltextzugriff (PDF)

Antiphospholipid arterial vasculopathy

Journal of rheumatology, 1989-06, Vol.16 (6), p.762

1989

Volltextzugriff (PDF)

Clinical manifestations of the antiphospholipid syndrome

Journal of rheumatology, 1992-11, Vol.19 (11), p.1778

Alarcón-Segovia, D

1992

Volltextzugriff (PDF)

Treatment needed to achieve remission of SLE

Lupus, 1999-01, Vol.8 (7), p.566-1

Alarcón-Segovia, D

1999

Volltextzugriff (PDF)

Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature

Journal of rheumatology, 1990-11, Vol.17 (11), p.1458

1990

Volltextzugriff (PDF)

The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity

The Israel Medical Association journal, 2000-05, Vol.2 (5), p.382-387

2000

Volltextzugriff (PDF)

Differential Oncogene and TNF‐α mRNA Expression in Bone Marrow Cells from Systemic Lupus Erythematosus Patients

Scandinavian journal of immunology, 1998-11, Vol.48 (5), p.551-556

1998

Volltextzugriff (PDF)

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

The Journal of clinical investigation, 1982-06, Vol.69 (6), p.1388-1392

1982

Volltextzugriff (PDF)

Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE)

Lupus, 1997-01, Vol.6 (1), p.57-62

1997

Volltextzugriff (PDF)

1 – 25 von 498

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(400)
Mit Volltextzugriff
(276)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(410)
Science & Technology
(307)
Life Sciences & Biomedicine
(306)
Female
(210)
Adult
(176)
Rheumatology
(167)
Male
(148)
Biological And Medical Sciences
(115)
Middle Aged
(113)
Medical Sciences
(109)
Lupus Erythematosus, Systemic - Immunology
(104)
Adolescent
(76)
Aged
(57)
Lupus Erythematosus, Systemic - Complications
(56)
General & Internal Medicine
(53)
Medicine, General & Internal
(51)
Immunology
(47)
T-Lymphocytes - Immunology
(46)
Systemic Lupus Erythematosus
(37)
Animals
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo

Prophylaxis of the antiphospholipid syndrome: a consensus report

Vasculitis in systemic lupus erythematosus

Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE: a unifying hypothesis

Primary antiphospholipid syndrome

Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients

Vasculitis and the antiphospholipid syndrome

Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices

Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus

Antinuclear antibodies: to penetrate or not to penetrate, that was the question

Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin

Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies

The recovery of self tolerance in SLE

Penetration of autoantibodies into living cells, 2000

Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus

Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission

The future of treatment for systemic lupus erythematosus

Antiphospholipid arterial vasculopathy

Clinical manifestations of the antiphospholipid syndrome

Treatment needed to achieve remission of SLE

Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature

The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity

Differential Oncogene and TNF‐α mRNA Expression in Bone Marrow Cells from Systemic Lupus Erythematosus Patients

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE)

Suchergebnisse filtern